Medicxi is a life sciences investment firm established by the former Index Ventures’s life science team, a technology-oriented venture capital. The two venture firms operate under the asset-centric investment model, concentrating on a single asset of a company and cooperating with entrepreneurial scientists. Medicxi focuses on drug discovery and therapeutic development for unmet medical needs, with an investment strategy that favors biotech companies with a single drug in development. This approach goes against the common practice of keeping 'backup' candidate drugs in case the lead program goes wrong.

Investment size
€0 to €5M+
Late seed
Early Growth
Investment Geography
Estonia, Latvia, Lithuania, Czech Republic, Slovakia, Albania, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Denmark, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Liechtenstein, Luxembourg, North Macedonia, Malta, Moldova, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovenia, Spain, Sweden, Switzerland, Ukraine, UK, France
Join Vestbee
Join the leading matchmaking platform for startups, VC funds, angels, accelerators and corporates
Join Now